Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,164 | -140,729 | -107,773 | -71,770 | -28,974 |
| Depreciation Amortization | 167 | 834 | 643 | 452 | 245 |
| Accounts payable and accrued liabilities | -6,673 | 10,507 | 11,043 | 12,273 | -2,074 |
| Other Working Capital | -7,520 | 5,270 | 7,389 | 8,225 | -5,395 |
| Other Operating Activity | 12,092 | 1,368 | -1,831 | -6,104 | 4,820 |
| Operating Cash Flow | $-36,098 | $-122,750 | $-90,529 | $-56,924 | $-31,378 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,873 | -24,585 | 114,542 | 72,812 | 24,352 |
| PPE Investments | N/A | -3,385 | -3,385 | -3,126 | -811 |
| Investing Cash Flow | $28,873 | $-27,970 | $111,157 | $69,686 | $23,541 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 707 | 163,474 | 1,511 | 814 | 316 |
| Financing Cash Flow | $707 | $163,474 | $1,511 | $814 | $316 |
| Beginning Cash Position | 62,697 | 49,943 | 49,943 | 49,943 | 49,943 |
| End Cash Position | 56,179 | 62,697 | 72,082 | 63,519 | 42,422 |
| Net Cash Flow | $-6,518 | $12,754 | $22,139 | $13,576 | $-7,521 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,098 | -122,750 | -90,529 | -56,924 | -31,378 |
| Capital Expenditure | N/A | -3,385 | -3,385 | -3,126 | -811 |
| Free Cash Flow | -36,098 | -126,135 | -93,914 | -60,050 | -32,189 |